RUBRIC CAPITAL MANAGEMENT LP purchased 8.9% of their position (2.39M shares) of HERON THERAPEUTICS, INC. /DE/ on the open market
Open‑market purchase worth $3.58M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2025ACC: 0000902664-25-003535
Other
Since Jan 2023
+2.48M
Net shares
Net buyer
$3.58M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
2.48M acquired
Non-Derivative Transactions1
Common Stock, par value $0.01 per share ("Common Stock")
Indirect
Shares
+2.39M
Price / share
$1.50
Trade value
$3.58M
% of position
8.9%
8/8/2025
26.71M→29.10M
Total
Net shares
+2.39M
Net value
$3.58M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share ("Common Stock") Indirect | 8/8/2025 | P · Purchase | +2.39M | $1.50 | $3.58M | 8.9% | 26.71M | 29.10M |
| Total | +2.39M | $3.58M | ||||||
Derivative Transactions2
Convertible Senior Unsecured Promissory Notes ("Notes")
Indirect
Converts to
See footnote
Shares
+N/A
Strike price
Held after
N/A
Exercisable
—
8/8/2025
Series A Convertible Preferred Stock ("Preferred Shares")
Indirect
Converts to
Common Stock
946.10K shares
Shares
+94.61K
Strike price
Held after
94.61K
Exercisable
—
8/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Senior Unsecured Promissory Notes ("Notes") Indirect | See footnote | 8/8/2025 | P · Purchase | +N/A | — | N/A | |
| Series A Convertible Preferred Stock ("Preferred Shares") Indirect | Common Stock946.10K shares | 8/8/2025 | P · Purchase | +94.61K | — | 94.61K |